Close
Novotech
Jabsco PureFlo 21 Single Use

News

Taking the strain out of cancer diagnostics 

Rainin electronic pipettes are helping California-based Clarient Diagnostic Services, Inc. to provide cancer diagnostic testing. Flow cytometry supervisor Brian Ngo explained: “Our laboratory uses flow cytometry to detect specific biomarkers that help to diagnose leukaemia, and...

Patheon Named Supply Chain Resiliency Partner Of The Year

Patheon N.V. ,a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced that the company was selected as the winner of the “Supply Chain Resiliency Partner of the Year” award by...

eRegulatory Summit – Expert Speaker Post

Join the experts at this year's eRegulatory Summit for all the latest industry updates, regulatory advice, practical guidance & ample case studies for benchmarking strategies in 3 key areas:    Regulatory Information Management & IDMP...

Clintec marks 20th year of global clinical research with launch of new brand

Clintec announces the launch of its new brand identity – reflected in their newly created website. This in part marks Clintec’s 20th anniversary and the achievement of significant milestones following another year of substantial growth, together with a succession...

GW Pharmaceuticals Achieves Positive Results in Phase 2 Proof of Concept Study in Glioma

GW Pharmaceuticals plc , a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform. GW Pharmaceuticals announced positive top-line results from an exploratory Phase 2 placebo-controlled clinical study of a...

Intarcia Announces FDA Filing Acceptance of NDA for ITCA 650 for the Treatment of Type 2 Diabetes

Intarcia Therapeutics, Inc. announced that the U.S. FDA has accepted for active review its NDA for ITCA 650, an investigational therapy for the treatment of type 2 diabetes (T2D).  Intarcia looks forward to working closely with...

Clinerion Introduces New Services for Market Access

Clinerion announces new services for market access which give pharmaceutical companies insight into patient populations based on its health data analytics tools. Clinerion’s Patient Recruitment System (PRS) Patient Finder tool has a wealth of health data...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »